COYA
Price:
$7.04
Market Cap:
$107.16M
Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a Treg-enhancing biologic for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination f...[Read more]
Industry
Biotechnology
IPO Date
2022-12-29
Stock Exchange
NASDAQ
Ticker
COYA
According to Coya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -9.51. This represents a change of -1215.20% compared to the average of 0.85 of the last 4 quarters.
The mean historical PE Ratio of Coya Therapeutics, Inc. over the last ten years is -20.51. The current -9.51 PE Ratio has changed 4.54% with respect to the historical average. Over the past ten years (40 quarters), COYA's PE Ratio was at its highest in in the December 2023 quarter at 21.08. The PE Ratio was at its lowest in in the September 2021 quarter at -8.31.
Average
-20.51
Median
-9.26
Minimum
-60.33
Maximum
-3.21
Discovering the peaks and valleys of Coya Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 193.61%
Maximum Annual PE Ratio = -3.21
Minimum Annual Increase = -84.95%
Minimum Annual PE Ratio = -60.33
Year | PE Ratio | Change |
---|---|---|
2023 | -9.43 | 193.61% |
2022 | -3.21 | -64.64% |
2021 | -9.08 | -84.95% |
The current PE Ratio of Coya Therapeutics, Inc. (COYA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.24
5-year avg
-20.51
10-year avg
-20.51
Coya Therapeutics, Inc.’s PE Ratio is less than Cue Biopharma, Inc. (-1.62), less than Lantern Pharma Inc. (-2.01), less than Fennec Pharmaceuticals Inc. (44.50), less than Eliem Therapeutics, Inc. (-2.42), less than Acumen Pharmaceuticals, Inc. (-2.64), less than Inozyme Pharma, Inc. (-3.05), less than Terns Pharmaceuticals, Inc. (-5.39), greater than Day One Biopharmaceuticals, Inc. (-16.94), less than Galera Therapeutics, Inc. (-0.09), less than Cognition Therapeutics, Inc. (-0.61), less than TFF Pharmaceuticals, Inc. (-0.37), less than TScan Therapeutics, Inc. (-5.38), less than Dermata Therapeutics, Inc. (-0.08), less than NewAmsterdam Pharma Company N.V. (-7.34), greater than Centessa Pharmaceuticals plc (-10.88), less than Sutro Biopharma, Inc. (-2.32), less than Opthea Limited (-1.57), less than HilleVax, Inc. (-0.59), less than Gain Therapeutics, Inc. (-2.06), less than aTyr Pharma, Inc. (-2.33), less than IN8bio, Inc. (-0.40),
Company | PE Ratio | Market cap |
---|---|---|
-1.62 | $91.52M | |
-2.01 | $35.63M | |
44.50 | $118.74M | |
-2.42 | $342.68M | |
-2.64 | $170.93M | |
-3.05 | $273.52M | |
-5.39 | $585.99M | |
-16.94 | $1.29B | |
-0.09 | $2.72M | |
-0.61 | $18.90M | |
-0.37 | $6.83M | |
-5.38 | $262.22M | |
-0.08 | $1.85M | |
-7.34 | $1.49B | |
-10.88 | $1.77B | |
-2.32 | $290.97M | |
-1.57 | $667.87M | |
-0.59 | $93.10M | |
-2.06 | $59.24M | |
-2.33 | $131.12M | |
-0.40 | $13.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Coya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Coya Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Coya Therapeutics, Inc. (COYA)?
What is the highest PE Ratio for Coya Therapeutics, Inc. (COYA)?
What is the 3-year average PE Ratio for Coya Therapeutics, Inc. (COYA)?
What is the 5-year average PE Ratio for Coya Therapeutics, Inc. (COYA)?
How does the current PE Ratio for Coya Therapeutics, Inc. (COYA) compare to its historical average?